Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Detection of RNA-DNA association by a proximity ligation-based method.

Petruk S, Fenstermaker TK, Black KL, Brock HW, Mazo A.

Sci Rep. 2016 Jun 3;6:27313. doi: 10.1038/srep27313.

2.

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, Maude SL, Raman P, Barrera A, Gill S, Lacey SF, Melenhorst JJ, Allman D, Jacoby E, Fry T, Mackall C, Barash Y, Lynch KW, Maris JM, Grupp SA, Thomas-Tikhonenko A.

Cancer Discov. 2015 Dec;5(12):1282-95. doi: 10.1158/2159-8290.CD-15-1020. Epub 2015 Oct 29.

3.

Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Li S, Ljubimov V, Moyseyev M, Daley D, Fuchs DT, Pham M, Black KL, Rentsendorj A, Koronyo-Hamaoui M.

Brain. 2015 Aug;138(Pt 8):2399-422. doi: 10.1093/brain/awv150. Epub 2015 Jun 6.

4.

Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.

Patil R, Gangalum PR, Wagner S, Portilla-Arias J, Ding H, Rekechenetskiy A, Konda B, Inoue S, Black KL, Ljubimova JY, Holler E.

Macromol Biosci. 2015 Sep;15(9):1212-7. doi: 10.1002/mabi.201500062. Epub 2015 Jun 2.

5.

Quality of surgical care and readmission in elderly glioblastoma patients.

Nuño M, Ly D, Mukherjee D, Ortega A, Black KL, Patil CG.

Neurooncol Pract. 2014 Jun;1(2):33-39. Epub 2014 May 19.

6.

MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain.

Patil R, Ljubimov AV, Gangalum PR, Ding H, Portilla-Arias J, Wagner S, Inoue S, Konda B, Rekechenetskiy A, Chesnokova A, Markman JL, Ljubimov VA, Li D, Prasad RS, Black KL, Holler E, Ljubimova JY.

ACS Nano. 2015 May 26;9(5):5594-608. doi: 10.1021/acsnano.5b01872. Epub 2015 May 6.

7.

Quantitative analysis of PMLA nanoconjugate components after backbone cleavage.

Ding H, Patil R, Portilla-Arias J, Black KL, Ljubimova JY, Holler E.

Int J Mol Sci. 2015 Apr 16;16(4):8607-20. doi: 10.3390/ijms16048607.

8.

Polymalic acid-based nano biopolymers for targeting of multiple tumor markers: an opportunity for personalized medicine?

Ljubimova JY, Ding H, Portilla-Arias J, Patil R, Gangalum PR, Chesnokova A, Inoue S, Rekechenetskiy A, Nassoura T, Black KL, Holler E.

J Vis Exp. 2014 Jun 13;(88). doi: 10.3791/50668.

9.

ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.

Koronyo-Hamaoui M, Shah K, Koronyo Y, Bernstein E, Giani JF, Janjulia T, Black KL, Shi PD, Gonzalez-Villalobos RA, Fuchs S, Shen XZ, Bernstein KE.

Curr Hypertens Rep. 2014 Jul;16(7):444. doi: 10.1007/s11906-014-0444-x. Review.

10.

Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Bernstein KE, Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Lopes DH, Shah KH, Bernstein EA, Fuchs DT, Yu JJ, Pham M, Black KL, Shen XZ, Fuchs S, Koronyo-Hamaoui M.

J Clin Invest. 2014 Mar;124(3):1000-12.

11.

Stepwise histone modifications are mediated by multiple enzymes that rapidly associate with nascent DNA during replication.

Petruk S, Black KL, Kovermann SK, Brock HW, Mazo A.

Nat Commun. 2013;4:2841. doi: 10.1038/ncomms3841.

12.

The somatic genomic landscape of glioblastoma.

Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L; TCGA Research Network.

Cell. 2013 Oct 10;155(2):462-77. doi: 10.1016/j.cell.2013.09.034. Erratum in: Cell. 2014 Apr 24;157(3):753.

13.

Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.

Ljubimova JY, Portilla-Arias J, Patil R, Ding H, Inoue S, Markman JL, Rekechenetskiy A, Konda B, Gangalum PR, Chesnokova A, Ljubimov AV, Black KL, Holler E.

J Drug Target. 2013 Dec;21(10):956-67. doi: 10.3109/1061186X.2013.837470. Epub 2013 Sep 16.

14.

Exploitation of adaptive evolution in glioma treatment.

Cordner R, Black KL, Wheeler CJ.

CNS Oncol. 2013 Mar;2(2):171-9. Review.

15.

High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era.

Patil CG, Nuño M, Elramsisy A, Mukherjee D, Carico C, Dantis J, Hu J, Yu JS, Fan X, Black KL, Bannykh SI.

Neuro Oncol. 2013 Jan;15(1):104-11. doi: 10.1093/neuonc/nos272. Epub 2012 Oct 31.

16.

Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid).

Patil R, Portilla-Arias J, Ding H, Konda B, Rekechenetskiy A, Inoue S, Black KL, Holler E, Ljubimova JY.

Int J Mol Sci. 2012;13(9):11681-93. doi: 10.3390/ijms130911681. Epub 2012 Sep 17.

17.

Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.

Ding H, Portilla-Arias J, Patil R, Black KL, Ljubimova JY, Holler E.

Biomaterials. 2013 Jan;34(1):217-25. doi: 10.1016/j.biomaterials.2012.08.016. Epub 2012 Oct 9.

18.

TrxG and PcG proteins but not methylated histones remain associated with DNA through replication.

Petruk S, Sedkov Y, Johnston DM, Hodgson JW, Black KL, Kovermann SK, Beck S, Canaani E, Brock HW, Mazo A.

Cell. 2012 Aug 31;150(5):922-33. doi: 10.1016/j.cell.2012.06.046. Epub 2012 Aug 23.

19.

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuño MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS.

Cancer Immunol Immunother. 2013 Jan;62(1):125-35. doi: 10.1007/s00262-012-1319-0. Epub 2012 Jul 31.

20.

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.

Yin D, Ogawa S, Kawamata N, Leiter A, Ham M, Li D, Doan NB, Said JW, Black KL, Phillip Koeffler H.

Oncogene. 2013 Feb 28;32(9):1155-63. doi: 10.1038/onc.2012.132. Epub 2012 May 14.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk